Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Caribou Biosciences (CRBU) Leases (2022 - 2025)

Caribou Biosciences (CRBU) has disclosed Leases for 4 consecutive years, with $17.7 million as the latest value for Q4 2025.

  • Quarterly Leases fell 11.69% to $17.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.7 million through Dec 2025, down 11.69% year-over-year, with the annual reading at $17.7 million for FY2025, 11.69% down from the prior year.
  • Leases for Q4 2025 was $17.7 million at Caribou Biosciences, up from $16.0 million in the prior quarter.
  • The five-year high for Leases was $25.7 million in Q1 2022, with the low at $16.0 million in Q3 2025.
  • Average Leases over 4 years is $21.5 million, with a median of $21.9 million recorded in 2023.
  • The sharpest move saw Leases decreased 7.9% in 2023, then dropped 22.11% in 2025.
  • Over 4 years, Leases stood at $24.2 million in 2022, then decreased by 8.45% to $22.2 million in 2023, then dropped by 9.8% to $20.0 million in 2024, then dropped by 11.69% to $17.7 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $17.7 million, $16.0 million, and $16.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.